
Centene Corporation CNC
$ 44.02
-1.31%
Annual report 2025
added 02-17-2026
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NYSESPB |
Shares |
493 M |
Market Cap[1] |
$ 21.7 B |
EBITDA (LTM) |
$ 3.57 B |
P/E (LTM) |
16.07 |
P/S (LTM) |
0.17 |
EPS (LTM) |
2.74 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 283.82 | -2.38 % | $ 74.8 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 182.36 | -2.61 % | $ 22 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
Molina Healthcare
MOH
|
$ 145.25 | -4.7 % | $ 7.67 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 80.64 | -1.21 % | $ 102 B | NYSE,SPB | ||
|
NovoCure Limited
NVCR
|
$ 13.28 | -1.78 % | $ 1.48 B | Nasdaq Global Select Market,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 289.21 | -1.93 % | $ 263 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.